METHOD OF TREATING POSTINJECTION INFILTRATES IN ONCOLOGY PATIENTS Russian patent published in 2015 - IPC A61N5/67 A61N2/06 A61K33/00 A61P41/00 

FIELD: medicine.

SUBSTANCE: from the first day a postinjection infiltrate has been found or at a later point in time, the infiltrate is exposed to infrared laser light in a constant magnetic field. The magnetic field strength falls within the range of 20-50 mT; an infrared laser pulse repetition frequency ranges within 80 Hz, whereas a transmission power is 0.25-0.5 W. The infiltrate is exposed to a defocused laser beam in the contact labile or distant labile mode at 0.3 cm for 15-25 seconds. Thereafter, tissues wetted in a hypertonic solution are applied 1-3 times a day. The therapeutic course makes 5-8 daily procedures.

EFFECT: shortening the length of the infiltrate resolution ensured by the anti-oedema, anti-inflammatory, restorative effect produced by the exposure that enables normalising the blood and lymph circulation within the infiltrate and all around, and improving local immunity.

1 ex